Hydroxamate sulfonamides as cd23 shedding inhibitors
申请人:Owen Alan David
公开号:US20060276507A1
公开(公告)日:2006-12-07
A class of piperidine and related heterocyclic derivatives, C-substituted by a substituted aryl or heteroaryl moiety, and N-substituted by an ethylsulfonyl group which in turn is substituted at the 2-position by a hydroxamic acid moiety and also by a range of alternative substituents, being potent inhibitors of CD23 shedding, are useful in the treatment and/or prevention of allergic, inflammatory and neoplastic diseases.
HYDROXAMATE SULFONAMIDES AS CD23 SHEDDING INHIBITORS
申请人:Celltech R & D Limited
公开号:EP1648868B1
公开(公告)日:2006-11-15
[EN] HYDROXAMATE SULFONAMIDES AS CD23 SHEDDING INHIBITORS<br/>[FR] HYDROXAMATE SULFONAMIDES UTILISES EN TANT QU'INHIBITEURS DE L'ELIMINATION DE CD23
申请人:CELLTECH R&D LTD
公开号:WO2004113298A1
公开(公告)日:2004-12-29
A class of piperidine and related heterocyclic derivatives, C-substituted by a substituted aryl or heteroaryl moiety, and N-substituted by an ethylsulfonyl group which in turn is substituted at the 2-position by a hydroxamic acid moiety and also by a range of alternative substituents, being potent inhibitors of CD23 shedding, are useful in the treatment and/or prevention of allergic, inflammatory and neoplastic diseases.